CELA PELOQUIN: Open Payments
NPI 1356084842 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $333 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $136 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $120 |
| ACADIA Pharmaceuticals Inc | 4 | $56 |
| Integra LifeSciences Corporation | 1 | $30 |
| SK Life Science, Inc. | 1 | $25 |
| CGG Medical Inc | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| CSL Behring | 1 | $16 |
| Neurelis, Inc. | 1 | $15 |
Products named: KYPHON EXPRESS II KYPHOPAK TRAY, JOURNAVX, NUPLAZID, CODMAN CERTAS, Briviact, INBRIJA, Hizentra, VALTOCO.
Industry payments across FL — which companies pay providers there.
